Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Charlton

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Pharmacology, Biochemistry, and Behavior|September 6, 2000
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in ratsN S Lamango, C G Charlton
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1985
Characterization and segmental distribution of 125I-Bolton-Hunter-labeled substance P binding sites in rat spinal cordC G Charlton, C J Helke
Synapse (New York, N.Y.)|January 1, 1988
Identification of motor neurons for accessory muscles of inspiration and expiration, pectoralis, trapezius and external oblique: comparison with non-respiratory skeletal muscleC G Charlton, B Crowell, R Benson
Life Sciences|June 16, 2000
Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopaX X Liu, K Wilson, C G Charlton
Neuroscience|June 15, 2010
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrationG Muthian, V Mackey, J King, et al.
Brain Research|February 25, 1985
Suicide transport of ricin demonstrates the presence of substance P receptors on medullary somatic and autonomic motor neuronsC J Helke, C G Charlton, R G Wiley
Pharmacology, Biochemistry, and Behavior|February 23, 2000
Quantification of S-adenosylmethionine-induced tremors: a possible tremor model for Parkinson's diseaseN S Lamango, R A Nesby, C G Charlton
Peptides|January 1, 1985
Bulbospinal substance P and sympathetic regulation of the cardiovascular system: a reviewC J Helke, C G Charlton, J R Keeler
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1985
Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonistJ R Keeler, C G Charlton, C J Helke
Neuroscience|October 1, 1986
Studies on the cellular localization of spinal cord substance P receptorsC J Helke, C G Charlton, R G Wiley
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|September 6, 2000
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in ratsN S Lamango, C G Charlton
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1985
Characterization and segmental distribution of 125I-Bolton-Hunter-labeled substance P binding sites in rat spinal cordC G Charlton, C J Helke
Synapse (New York, N.Y.)|January 1, 1988
Identification of motor neurons for accessory muscles of inspiration and expiration, pectoralis, trapezius and external oblique: comparison with non-respiratory skeletal muscleC G Charlton, B Crowell, R Benson
Life Sciences|June 16, 2000
Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopaX X Liu, K Wilson, C G Charlton
Neuroscience|June 15, 2010
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrationG Muthian, V Mackey, J King, et al.
Brain Research|February 25, 1985
Suicide transport of ricin demonstrates the presence of substance P receptors on medullary somatic and autonomic motor neuronsC J Helke, C G Charlton, R G Wiley
Pharmacology, Biochemistry, and Behavior|February 23, 2000
Quantification of S-adenosylmethionine-induced tremors: a possible tremor model for Parkinson's diseaseN S Lamango, R A Nesby, C G Charlton
Peptides|January 1, 1985
Bulbospinal substance P and sympathetic regulation of the cardiovascular system: a reviewC J Helke, C G Charlton, J R Keeler
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1985
Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonistJ R Keeler, C G Charlton, C J Helke
Neuroscience|October 1, 1986
Studies on the cellular localization of spinal cord substance P receptorsC J Helke, C G Charlton, R G Wiley
Pageof 4